Pan-cancer analysis conducted with the TCGA database demonstrated a positive correlation between SOCS1 expression and TMB and MSI in certain cancers, and a significant positive correlation with immune scores in most cancers, including gliomas. This evidence concerns the gene SOCS1 and central nervous system cancer.